Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3

Supplementation with high doses of alpha-tocopherol has increased the oxidation resistance of LDL in many clinical trials. There have been only a few placebo-controlled trials in healthy persons of alpha-tocopherol doses usually contained in dietary supplements. We carried out a single-blind, placebo-controlled, randomized trial to examine the effect of 200 mg RRR-alpha-tocopheryl acetate/d on the oxidation resistance of atherogenic lipoproteins (VLDL+LDL including intermediate-density lipoproteins) in 40 smoking men. VLDL+LDL oxidation resistance was assessed as conjugated dienes after copper induction and hemin degradation after hydrogen peroxide induction. Also, the LDL total peroxyl-radical trapping antioxidant parameter (LDL TRAP) and plasma malondialdehyde were measured at baseline and after 2 mo of supplementation. Plasma RRR-alpha-tocopherol concentrations were measured at 2-h intervals for 12 h at baseline and after 2 mo of supplementation. Compared with placebo, 200-mg RRR-alpha-tocopheryl acetate supplementation elevated plasma and VLDL+LDL alpha-tocopherol concentrations, LDL TRAP, and oxidation resistance of VLDL+LDL. Plasma alpha-tocopherol increased by 88% (P < 0.0001), VLDL+LDL alpha-tocopherol increased by 90% (P < 0.0001), and LDL TRAP by 58% (P < 0.0001). The time to the start of oxidation (lag time) was prolonged by 34% when assessed with a copper-induced method and by 109% when assessed with a hemin + hydrogen peroxide-induced method; the time to maximal oxidation was prolonged by 21% (copper-induced method) in the vitamin E-supplemented group. Changes in plasma alpha-tocopherol, lipid-standardized alpha-tocopherol, and VLDL+LDL alpha-tocopherol correlated significantly with changes in LDL TRAP, lag time, and time to maximal oxidation. Differences in changes between groups in the area under the curve for plasma alpha-tocopherol were significant (P < 0.009). Our results suggest that 200 mg oral RRR-alpha-tocopheryl acetate/d had a clear effect on the in vitro oxidation of VLDL+LDL in smoking men.     

Quantitative patterns in the clinical manifestations of radiation sickness in large laboratory animals exposed to radiation at superlethal doses. The quantitative patterns in the manifestations of radiation sickness in dogs

Radiation sickness manifestations have been studied in dogs exposed to electrons (electron energy 25 MeV) and gamma-neutron radiation (neutron energies of 0.37 and 1.2 MeV) in a wide dose range. Dose-response relationships have been calculated for mortality and some clinical manifestations of the intestinal and cerebral forms of radiation sickness. With regard to mortality, the highest effect has been observed for gamma-neutron radiation with a neutron energy of 1.2 MeV. For equal physical doses and for those equally effective in relation to mortality, clinical manifestations of damage are more prominent following exposure to electrons.     

新型微合金非调质钢的研究

研制了一种新型微合金非调质钢。通过合理设计合金成分,改善熔炼脱氧过程,控制钢中氧化物的组成、分布、形状和尺寸,在研制钢中形成微细的氧化物夹杂作为晶内铁素体最有利的析出位置。通过晶内铁素体的析出细化了晶粒,提高了钢的强度与韧性。将研制的新型微合金非调质钢用于拖拉机的牵引插销是可行且有效的。     

Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas

Carcinoma in ulcerative colitis (UC) develops from dysplastic precursor lesions, which include flat dysplasia (FD) and polypoid dysplasias (PD). PD may present as single or multiple polypoid structures or as plaque-like lesions that, independent of histological grade, are an indication for colectomy. PDs are histologically similar to adenomas and may not be readily distinguished by light microscopy. It is not known whether FD and PD are different entities, or whether they represent etiologically similar lesions with different morphological expression. We microdissected 25 cases of UC with PD and 19 samples of FD with surrounding chronic colitis (CC) in UC. Loss of heterozygosity (LOH) at the von Hippel Lindau (vHL) gene locus and the putative tumor suppressor genes APC, INK4A (9p16), and p53 was studied. LOH of the vHL gene, INK4A (9p16), and APC was also studied in 11 sporadic adenomas of the colon. LOH at the vHL locus was present in 50% of the samples of PD and in 12% of the samples of FD. LOH was seen in CC close to PD and FD in 26% and 12% of cases, respectively. No adenoma showed LOH of the vHL gene markers studied. LOH in p53 was seen in PD in 16% cases and in FD in 42% cases and in CC close to PD and FD in 0% and 14% cases, respectively. LOH patterns between PD and FD of the markers for APC and 9p16 were not different. LOH in APC was seen in two of five cases of adenoma. We conclude that PD and FD share genetic alterations in APC and 9p16 genes. More frequent involvement of the VHL gene in PD and surrounding CC and involvement of p53 in HGD and CC in FD may represent genetic differences between the development of PD and FD and may be the cause of the different morphology. The infrequency of LOH at the vHL locus in adenomas versus PD may serve as a discriminator between adenomas and PD in diagnostically problematic cases.     

基于OPNET的高速列车控制网络负载平衡研究

随着工业以太网应用于高速列车并成为其控制网络,将可能出现带宽、吞吐量等一系列技术问题。采用基于流水线R—R的负载平衡调度算法,通过OPNET软件建模并调用该算法进行仿真。仿真结果表明,该算法在列车控制网络中的应用是可行的,能较好地解决列车控制网络的负载平衡问题。     

基于非竞争机制的改进GAF拓扑控制算法

能量问题是制约无线传感器网络发展和应用的瓶颈之一。为均衡网络节点的能量消耗,延长网络的生命周期,需要建立高效的拓扑控制机制。在深入研究GAF算法的基础上,提出了一种基于非竞争机制的改进算法。利用建立的适合度函数和顺序表优化了簇头的选举策略;通过改进虚拟单元格的划分方法,并推导出动态剩余能量阈值估算公式,有效地改善了GAF算法的相关性能。仿真结果表明,改进算法对于减少拓扑控制耗费、延长网络生命周期具有显著效果。     

跨越架线辅助装置在配网放线施工中的应用

针对安装架空线路时存在的安全及运行隐患,研发了一种跨越架线作业的风险控制装置,并将其应用到配网放线施工中,达到了良好的效果,能够提高导线的架设效率,降低成本,提升安全水平.     

利用电阻探针对石油设备及管道的腐蚀进行监测

从1998年起，国内石油炼制行业开始大量炼制进口高硫原油，油气管道的腐蚀问题受到了重视。介绍了电阻探针腐蚀监测系统的原理及组成。并针对油气管道，实施了在线监测，安装了6组腐蚀电阻探针，分析了测量结果，为今后防腐工作提供了依据。